September 26, 2019
Rose
Also, Novartis AG’s Sandoz unit recalled its generic version of the drug, called ranitidine, on Tuesday, confirming it had found worrisome levels of the carcinogen called NDMA.
from Kaiser Health News https://ift.tt/2lnzwNN
September 26, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
‘Block Grant’ Has Become A Big Buzzword For Tennessee Politicians Discussing Medicaid. Here’s What It Entails.- State Highlights: Charges Expected In Nursing Home Deaths During Florida Hurricane; Multiple Blunders Led To Water Crisis In Newark
- Many Treatments Might Not Make Us Better. Others Harm Us, But Getting Doctors To Stop Using Them Takes A Long Time, Group Says
- California Officials Warn Disneyland-Goers That They May Have Been Exposed To Measles By New Zealand Tourist
- Pancreatic Cancer Is So Lethal Because Patients Rarely Have Symptoms In Early Stages Of Disease
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment